Several chronic neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), and Parkinson’s disease (PD), are also linked to increased activation of RIPK1 [122,123,124]. Here, RIPK1 is linked to Alzheimer disease.